advanced search
2023_June_SMI_London_leaderboard
Alan Shortall
Chief Executive Officer

Is this your profile?

About

Alan Shortall was the Chief Executive Officer of Unilife.

Contributions

PROVIDING PHARMACEUTICAL COMPANIES WITH MARKET-LEADING WEARABLE INJECTORS
Unilife highlights some of the key reasons its customer-centric strategy is helping it establish long-term, commercial relationships with many leading pharmaceutical companies and industry suppliers.

More contributions

DELIVERING VALUE FOR INJECTABLES: UNMET NEEDS, DEVICE SOLUTIONS & THERAPEUTIC OUTCOMES
Unilife examines why pharmaceutical companies are leveraging innovative delivery systems to enhance and differentiate their injectable products so that they can generate powerful value-based.
WEARABLES
SELECTING THE RIGHT WEARABLE INJECTOR TECHNOLOGY AND PARTNER
In this article, Alan Shortall provides a detailed run-down of how Unilife’s wearable devices portfolio meets the numerous requirements that pharma partners and patients demand of such a devices, and explains how this differentiates Unilife’s products from others in the space.
PREFILLED SYRINGES
PROVIDING FULL-SERVICE SOLUTIONS FOR INJECTABLE DRUG DELIVERY
Alan Shortall provides an introduction to some significant trends in the pharma industry, such as the use of smart phone apps and the move of injectable medication delivery away from the clinical setting.
WEARABLES
CRITERIA FOR SELECTING A WEARABLE INJECTOR TECHNOLOGY AND PARTNER
Alan Shortall provides a detailed account of the significant opportunities that wearable injection devices present pharmaceutical and biotech companies.
Top